HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hugo H Ortega Selected Research

Follicular Cyst (Follicular Cysts)

10/2015Characterization of persistent follicles induced by prolonged treatment with progesterone in dairy cows: an experimental model for the study of ovarian follicular cysts.
12/2014mRNA expression pattern of gonadotropin receptors in bovine follicular cysts.
8/2014Role of activin, inhibin, and follistatin in the pathogenesis of bovine cystic ovarian disease.
12/2012Alteration in localization of steroid hormone receptors and coregulatory proteins in follicles from cows with induced ovarian follicular cysts.
6/2012Steroid receptor mRNA expression in the ovarian follicles of cows with cystic ovarian disease.
11/2011Levels of heat shock protein transcripts in normal follicles and ovarian follicular cysts.
10/2010Cell proliferation and survival mechanisms underlying the abnormal persistence of follicular cysts in bovines with cystic ovarian disease induced by ACTH.
6/2008Insulin-like growth factor I in sera, ovarian follicles and follicular fluid of cows with spontaneous or induced cystic ovarian disease.
1/2008Characterization of pituitary cell populations in rats with induced polycystic ovaries.
10/2006Microscopic characterization of follicular structures in letrozole-induced polycystic ovarian syndrome in the rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hugo H Ortega Research Topics

Disease

12Ovarian Diseases (Ovarian Disease)
10/2019 - 06/2008
10Follicular Cyst (Follicular Cysts)
10/2015 - 10/2006
8Cysts
10/2019 - 06/2008
4Infections
09/2021 - 02/2014
4Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
01/2020 - 10/2006
3Body Weight (Weight, Body)
07/2020 - 03/2010
2Breast Neoplasms (Breast Cancer)
08/2021 - 01/2015
2Neoplasms (Cancer)
03/2021 - 07/2020
2Colonic Neoplasms (Colon Cancer)
11/2020 - 07/2020
2Ovarian Cysts (Ovarian Cyst)
10/2015 - 01/2004
2Inflammation (Inflammations)
04/2014 - 02/2014
1Osteoarthritis
12/2021
1COVID-19
09/2021
1Adenocarcinoma
08/2021
1Dosage-sensitive sex reversal
01/2020
1Persistent Infection
10/2017
1Neoplasm Metastasis (Metastasis)
01/2015
1Mastitis
02/2014
1Insulin Resistance
06/2010
1Hyperinsulinism (Hyperinsulinemia)
06/2010
1Hypoadiponectinemia
03/2010

Drug/Important Bio-Agent (IBA)

6Adrenocorticotropic Hormone (ACTH)FDA Link
01/2019 - 06/2008
6Proteins (Proteins, Gene)FDA Link
10/2017 - 12/2012
3Messenger RNA (mRNA)IBA
09/2021 - 06/2012
3SteroidsIBA
03/2021 - 06/2012
3Testosterone (Sustanon)FDA Link
01/2020 - 06/2010
3Heat-Shock Proteins (Heat-Shock Protein)IBA
12/2013 - 04/2010
2ProgesteroneFDA LinkGeneric
01/2017 - 10/2015
2AntralIBA
12/2014 - 05/2011
2Estradiol (Delestrogen)FDA LinkGeneric
09/2014 - 01/2008
1CelluloseIBA
12/2021
1HydrogelsIBA
12/2021
1GlycosaminoglycansIBA
12/2021
1VaccinesIBA
09/2021
1Bovine Serum AlbuminIBA
08/2021
1FITC-annexin A5IBA
08/2021
1GenisteinIBA
08/2021
1Coenzyme A Ligases (Acid-Thiol Ligases)IBA
03/2021
1Excipients (Suspending Agents)IBA
11/2020
1Free RadicalsIBA
07/2020
1Biological ProductsIBA
07/2020
1Antineoplastic Agents (Antineoplastics)IBA
07/2020
1Steroidogenic Factor 1IBA
01/2020
1CytokinesIBA
10/2019
1Interleukin-4 (Interleukin 4)IBA
10/2019
1Interleukin-8 (Interleukin 8)IBA
10/2019
1betaglycan (TGFBR3)IBA
01/2019
1Transforming Growth Factor-beta Type I ReceptorIBA
01/2019
1Transforming Growth Factor-beta Type II ReceptorIBA
01/2019
1Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
01/2019
1Activin Receptors (Activin Receptor)IBA
01/2019
1Prostaglandins EIBA
09/2018
1LactoferrinIBA
10/2017
1GlucocorticoidsIBA
01/2016
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
01/2016
1AndrogensIBA
06/2015
1Vasopressins (Vasopressin)IBA
01/2015
1Cytostatic AgentsIBA
01/2015
1Peptides (Polypeptides)IBA
01/2015
1Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric
01/2015
1FSH Receptors (FSH Receptor)IBA
12/2014
1Gonadotropin ReceptorsIBA
12/2014
1LH Receptors (LH Receptor)IBA
12/2014
1Inhibins (Inhibin)IBA
08/2014
1inhibin BIBA
08/2014
1activin AIBA
08/2014
1Activins (Activin)IBA
08/2014
1inhibin AIBA
08/2014
1FollistatinIBA
08/2014
1CollagenIBA
02/2014
1Transforming Growth Factor beta (TGF-beta)IBA
02/2014
1Protein Isoforms (Isoforms)IBA
02/2014
1Androgen Receptors (Androgen Receptor)IBA
12/2012
1Hormones (Hormone)IBA
12/2012
1Captopril (Capoten)FDA LinkGeneric
08/2012
1Steroid Receptors (Steroid Receptor)IBA
06/2012
1Insulin-Like PeptidesIBA
10/2011
1Insulin-Like Growth Factor Binding Protein 2IBA
10/2011
1Insulin-Like Growth Factor Binding Protein 3IBA
10/2011
1Neurotransmitter Agents (Neurotransmitter)IBA
05/2011
1Fatty Acids (Saturated Fatty Acids)IBA
03/2010
1Nonesterified Fatty Acids (NEFA)IBA
03/2010
1LeptinIBA
03/2010
1Plasminogen Activators (Plasminogen Activator)IBA
03/2010
1Biomarkers (Surrogate Marker)IBA
03/2010
1Insulin-Like Growth Factor I (IGF-1)IBA
06/2008
1Cadherins (E-Cadherin)IBA
10/2006
1Letrozole (Femara)FDA LinkGeneric
10/2006
1Cytoskeletal ProteinsIBA
01/2004

Therapy/Procedure

1Therapeutics
03/2021
1Oral Administration
07/2020